The North America Cell-Free DNA (cfDNA) Testing Market is witnessing robust growth due to the widespread adoption of advanced molecular diagnostics, increasing prevalence of cancer and genetic disorders, and growing demand for non-invasive prenatal testing (NIPT). The region benefits from strong healthcare infrastructure, high awareness of precision medicine, and continuous...